Abstract：Atrial fibrillation(AF) is a kind of clinically common arrhythmia, which can be divided into symptomatic and asymptomatic AF. Monitoring instruments for arrhythmia is various, which can be classified into external monitor and cardiac implantable devices. Despite being applied in diagnosing AF and its type, cardiac implantable devices can also be utilized in guiding the treatment of AF induced stroke and accurately evaluating the recurrence rate of AF after catheter ablation. This paper reviews on the above issues.
孙柳, 张树龙. 心脏植入性器械对心房颤动诊断价值的评价[J]. 实用心电学杂志, 2017, 26(1): 52-56.
SUN Liu, ZHANG Shu-Long. Evaluation of diagnostic value of cardiac implantable devices for atrial fibrillation. JOURNAL OF PRACTICAL ELECTROCARDIOLOGY, 2017, 26(1): 52-56.
[1] Capucci A，Santini M，Padeletti L，et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers[J]. J Am Coll Cardiol，2005，46(10):1913-1920.[2] Reiffel JA, Schwarzberg R, Murry M. Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24hour Holter monitors for arrhythmia detection[J]. Am J Cardiol, 2005, 95(9):1055-1059.[3] Cheung JW，Keating RJ，Stein KM，et al. Newly detected atrial fibrillation following dual chamber pacemaker implantation[J]. J Cardiovasc Electrophysiol，2006，17(12):1323-1328.[4] Healey JS，Martin JL，Duncan A，et al. Pacemakerdetected atrial fibrillation in patients with pacemakers: prevalence, predictors, and currentuse of oral anticoagulation[J]. Can J Cardiol，2013，29(2):224-228.[5] Healey JS，Connolly SJ，Gold MR，et al. Pacemakerdetected atrial tachyarrhythmias and the risk of stroke[J]. N Eng J Med 2012，366:122-131.[6] Zoppo F，Facchin D，Molon G，et al. Improving atrial fibrillation detection in patients with implantable cardiac devices by means of a remote monitoring and management application[J]. Pacing Clin Electrophysiol，2014，37(12):1610-1618.[7] [JP2]Israel CW, Grnefeld G, Ehrlich JR,et al. Longterm risk of recurrent atrial fibrillation as documented by an implantable monitoring device[J]. J Am Coll Cardiol, 2004, 43(1):47-52.[8] [JP2]Sugihara C，Veasey R，Freemantle N，et al. The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF[J]. Europace，2015，17(6):864-870.[9] Boriani G, Glotzer TV, Santini M, et al. Devicedetected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke prevention Strategies based on Atrial Fibrillation information from implanted devices)[J]. Eur Heart J，2014，35(8):508-516.[10] Healey JS，Connolly SJ，Gold MR，et al. Subclinical atrial fibrillation and the risk of stroke[J]. N Engl J Med，2012，366(2):120-129.[11] Gonzalez M，Keating RJ，Markowitz SM，et al. Newly detected atrial high rate episodes predict longterm mortality outcomes in patients with permanent pacemakers[J]. Heart Rhythm，2014，11(12):2214-2221.[12] Fuster V，Rydén LE，Cannom DS，et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J]. J Am Coll Cardiol，2011，57(11):e101-e198.[13] Fransen EJ. Reaction to the EHRA position paper: ′Indications for the use of diagnostic implantable and external ECG loop recorders′[J]. Europace，2009，11(11):1566.[14] Sugihara C，Veasey R，Freemantle N，et al. The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF [J]. Europace，2015，17(6):864-870.[15] Wolf P ，Abbott R，Kannel W. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study[J]. Stroke，1991，22(8):983-988.[16] Vanassche T，Lauw MN，Eikelboom JW，et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6 563 aspirintreated patients in ACTIVEA and AVERROES[J]. Eur Heart J，2015，36(5):281-288.[17] Lamas G. How much atrial fibrillation is too much atrial fibrillation？[J]. N Engl J Med，2012，366(2):178-180.[18] Glotzer TV，Daoud EG，Wyse DG，et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study[J]. Circ Arrhythm Electrophysiol，2009，2(5):474-480.[19] Daoud EG，Glotzer TV，Wyse DG，et al. Temporal relationship of atrial tachyarrhythmias，cerebrovascular events，and systemic emboli based on stored device data: a subgroup analysis of trends[J]. Heart Rhythm，2011，8(9):1416-1423.[20] Ip J，Waldo AL，Lip GY，et al. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverterdefibrillator and CRTD devices: Rationale，design，and clinical characteristics of the initially enrolled cohort The IMPAC study[J]. Am Heart J，[JP]2009，158(3):364-370.[21] Cairns JA，Connolly S，Mcmurtry S，et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter[J]. Can J Cardiol，2011，27(1):74-90.[22] Lellouche N，Jas P，Nault I，et al. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation[J]. J Cardiovasc Electrophysiol，2008，19(6):599-605.[23] Pokushalov E，Romanov A，Corbucci G，et al. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study[J]. Circ Arrhythm Electrophysiol，2011，4(6):823-831.
2017, Vol. 26 
